NP
CVS icon

NS Partners’s CVS Health CVS Stock Holding History

NS Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,975
Closed -$234K – 94
2018
Q3 		$234K Buy
+2,975
New +$213K 0.02% 94
2018
Q1 		– Sell
-2,975
Closed -$216K – 101
2017
Q4 		$216K Sell
2,975
-311
-9% -$22.6K 0.02% 103
2017
Q3 		$267K Sell
3,286
-250
-7% -$19.8K 0.03% 98
2017
Q2 		$285K Buy
3,536
+285
+9% +$22.5K 0.04% 96
2017
Q1 		$255K Sell
3,251
-93,223
-97% -$7.44M 0.04% 100
2016
Q4 		$7.61M Sell
96,474
-2,705
-3% -$219K 1.19% 32
2016
Q3 		$8.83M Sell
99,179
-2,841
-3% -$268K 1.44% 20
2016
Q2 		$9.77M Buy
102,020
+875
+0.9% +$87.2K 1.67% 16
2016
Q1 		$10.5M Buy
101,145
+8,402
+9% +$817K 1.89% 11
2015
Q4 		$9.07M Sell
92,743
-13,539
-13% -$1.33M 1.62% 15
2015
Q3 		$10.3M Sell
106,282
-2,470
-2% -$260K 1.8% 15
2015
Q2 		$11.4M Buy
+108,752
New +$11.1M 1.82% 12

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NS Partners's CVS Position: Q4 2018 in Review

NS Partners sold out of CVS Health (CVS) in Q4 2018, closing a stake of 2,975 shares — an estimated $234K sold.

NS Partners first reported a position in CVS in Q2 2015 and held it in 12 quarters. The position peaked at $11.4M in Q2 2015. 1,779 funds tracked by Wall St. Rank hold CVS as of Q4 2018.

  • NS Partners reported no remaining CVS Health position as of Q4 2018 after selling out during the quarter.
  • NS Partners sold 2,975 CVS Health shares in Q4 2018, an estimated $234K.
  • NS Partners first reported a position in CVS Health in Q2 2015 and held it in 12 quarters.
  • NS Partners's CVS Health position peaked at $11.4M in Q2 2015.
  • 1,779 funds tracked by Wall St. Rank held CVS Health as of Q4 2018.

Based on NS Partners's 13F filing for Q4 2018, filed 12 Feb 2019.